Rigel Pharmaceuticals
RIGL
RIGL
116 hedge funds and large institutions have $164M invested in Rigel Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 38 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
8% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 38
7% less capital invested
Capital invested by funds: $176M → $164M (-$11.8M)
Holders
116
Holding in Top 10
–
Calls
$1.04M
Puts
$50K
Top Buyers
| 1 | +$2.01M | |
| 2 | +$1.62M | |
| 3 | +$1.54M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.25M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.23M |
Top Sellers
| 1 | -$21.4M | |
| 2 | -$2.58M | |
| 3 | -$1.78M | |
| 4 |
BlackRock
New York
|
-$591K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$584K |